Stifel resumed coverage of Orthofix (OFIX) with a Buy rating and $22 price target The firm believes “profitable growth at an attractive valuation” makes it easier to own the shares as investors await long-term ET tailwinds benefiting 7D FLASH, the analyst says while resuming coverage of the spine industry.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OFIX: